Wu Shao-Chun, Chen Chao-Long, Wang Chih-Hsien, Huang Chia-Jung, Cheng Kwok-Wai, Shih Tsung-Hsiao, Yang Johnson Chia-Shen, Jawan Bruno
Department of Anesthesiology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, No. 123 Dapi Road, Niaosong, Kaohsiung, Taiwan.
Ann Transplant. 2012 Dec 31;17(4):64-71. doi: 10.12659/aot.883696.
After liver transplantation (LT), re-exploration of the abdomen to check for bleeding is sometime required. Our study aimed to identify the predictive factors by analysis of preoperative and intraoperative presentations that may impact the re-exploration for hemostasis.
MATERIAL/METHODS: We selected 522 consecutive recipients from the Liver Transplant Program database and medical records between January 1, 1994 and December 1, 2009 in our hospital. Demographic data (age, sex, body mass index, weight, MELD score), preoperative laboratory tests (Hb, platelet, albumin, bilirubin, INR, APTT), and intraoperative presentations (ascites and blood loss, crystalloids, 5% albumin infused, blood products used (such as LPRBC, RBC, FFP, platelet, cryoprecipitate), urine output, Hb at end of operation, and anesthesia) were collected for primary comparison. Potential predictors found by univariate comparison at p<0.1 were put into a multiple binary logistic regression model.
Thirty-eight (7.3%) recipients required re-exploration for hemostasis after LDLT; 80% needed re-exploration only once. In univariate analysis, recipients transfused with FFP >10 ml/kg had a 4.2-fold increased risk of re-exploration (p<0.001). Thirteen potential predictors by univariate comparison at p<0.1 were selected into a multiple binary logistic regression. Fresh frozen plasma (FFP) transfused was the sole predictor.
Each elevation of 1ml of transfused FFP per kg is associated with a 1.033-fold increased incidence of re-exploration for hemostasis. Patients transfused with more than 10 ml/kg FFP during LT require more intensive management within 72 hours due to increase risk of postoperative bleeding.
肝移植(LT)后,有时需要再次剖腹探查以检查是否出血。我们的研究旨在通过分析术前和术中表现来确定可能影响再次探查止血的预测因素。
材料/方法:我们从我院1994年1月1日至2009年12月1日的肝移植项目数据库和病历中选取了522例连续的受者。收集人口统计学数据(年龄、性别、体重指数、体重、终末期肝病模型(MELD)评分)、术前实验室检查(血红蛋白(Hb)、血小板、白蛋白、胆红素、国际标准化比值(INR)、活化部分凝血活酶时间(APTT))以及术中表现(腹水和失血量、晶体液、输注的5%白蛋白、使用的血液制品(如少白细胞红细胞(LPRBC)、红细胞(RBC)、新鲜冰冻血浆(FFP)、血小板、冷沉淀)、尿量、手术结束时的Hb以及麻醉情况)进行初步比较。通过单因素比较在p<0.1时发现的潜在预测因素被纳入多因素二元逻辑回归模型。
38例(7.3%)受者在活体肝移植(LDLT)后需要再次探查止血;80%的受者仅需再次探查一次。在单因素分析中,输注FFP>10 ml/kg的受者再次探查的风险增加4.2倍(p<0.001)。通过单因素比较在p<0.1时的13个潜在预测因素被选入多因素二元逻辑回归。输注的新鲜冰冻血浆(FFP)是唯一的预测因素。
每千克输注FFP增加1ml与再次探查止血的发生率增加1.033倍相关。肝移植期间输注FFP超过10 ml/kg的患者由于术后出血风险增加,在72小时内需要更密切的管理。